Company intelligence / Profile preview

Sabai Global

Chesterfield, Missouri, USAsabaiglobal.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Sabai Global is a leading provider of biosafety and ethical review services for clinical research, specializing in Institutional Biosafety Committee (IBC) and Institutional Review Board (IRB) reviews. The company has supported over 300 cell and gene therapy trials and works with more than 600 IBCs nationwide. Its expertise accelerates regulatory approval processes for drug development sponsors across oncology, rare disease, infectious disease, and regenerative medicine.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Cell therapyGene therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on Sabai Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sabai Global.

Explore the full profile